Low vitamin and carotenoid levels are related to cerebral white matter lesions

Journal of Nutrition, Health and Aging

Volumn 17, Issue 5, 2013, Pages 456-460

  Ohshima, Y ^a   Mizuno, Toshiki ^a   Yamada, K ^a   Matsumoto, S ^b   Nagakane, Y ^a   Kondo, M ^a   Kuriyama, N ^a   Miyazaki, T ^b   Takeda, K ^b   Nishimura, T ^a   Nakagawa, M ^a   Ozasa, K ^a,c   Watanabe, Y ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b KYOTO INDUSTRIAL HEALTH ASSOCIATION   (Japan)

^c RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

Author keywords

carotenoid; cerebral ischemia; magnetic resonance imaging; Vitamin; white matter lesion

Indexed keywords

ALPHA TOCOPHEROL; ASCORBIC ACID; BETA TOCOPHEROL; CAROTENOID; CYANOCOBALAMIN; DELTA TOCOPHEROL; GAMMA TOCOPHEROL; HOMOCYSTEINE; VITAMIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DEEP WHITE MATTER LESION; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING; SYSTOLIC BLOOD PRESSURE; VITAMIN BLOOD LEVEL; WHITE MATTER LESION;

EID: 85027941845     PISSN: 12797707     EISSN: 17604788     Source Type: Journal    
DOI: 10.1007/s12603-012-0419-z     Document Type: Article

References (25)

1. Gey KF. On the antioxidant hypothesis with regard to arteriosclerosis. Bibl Nutr Dieta 1986:53-91.
2. Diaz MN, Frei B, Vita JA, Keaney JF, Jr. Antioxidants and atherosclerotic heart disease. N Engl J Med 1997;337:408-416.
3. Hak AE, Ma J, Powell CB, Campos H, Gaziano JM, Willett WC, et al. Prospective study of plasma carotenoids and tocopherols in relation to risk of ischemic stroke. Stroke 2004;35:1584-1588.
4. Rissanen TH, Voutilainen S, Nyyssonen K, Lakka TA, Sivenius J, Salonen R, et al. Low serum lycopene concentration is associated with an excess incidence of acute coronary events and stroke: the Kuopio Ischaemic Heart Disease Risk Factor Study. Br J Nutr 2001;85:749-754.
5. Gey KF, Stahelin HB, Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke: Basel Prospective Study. Clin Investig 1993;71:3-6.
6. Voko Z, Hollander M, Hofman A, Koudstaal PJ, Breteler MM. Dietary antioxidants and the risk of ischemic stroke: the Rotterdam Study. Neurology 2003;61:1273-1275.
7. Hirvonen T, Virtamo J, Korhonen P, Albanes D, Pietinen P. Intake of flavonoids, carotenoids, vitamins C and E, and risk of stroke in male smokers. Stroke 2000;31:2301-2306.
8. Ascherio A, Rimm EB, Hernan MA, Giovannucci E, Kawachi I, Stampfer MJ, et al. Relation of consumption of vitamin E, vitamin C, and carotenoids to risk for stroke among men in the United States. Ann Intern Med 1999;130:963-970.
9. Fazekas F, Kleinert R, Offenbacher H, Schmidt R, Kleinert G, Payer F, et al. Pathologic correlates of incidental MRI white matter signal hyperintensities. Neurology 1993;43:1683-1689.
10. Fernando MS, O'Brien JT, Perry RH, English P, Forster G, McMeekin W, et al. Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain. Neuropathol Appl Neurobiol 2004;30:385-395.
11. Breteler MM, van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JH, et al. Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: the Rotterdam Study. Neurology 1994;44:1246-1252.
12. Longstreth WT, Jr., Manolio TA, Arnold A, Burke GL, Bryan N, Jungreis CA, et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study. Stroke 1996;27:1274-1282.
13. Liao D, Cooper L, Cai J, Toole JF, Bryan NR, Hutchinson RG, et al. Presence and severity of cerebral white matter lesions and hypertension, its treatment, and its control. The ARIC Study. Atherosclerosis Risk in Communities Study. Stroke 1996;27:2262-2270.
14. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke 1997;28:652-659.
15. den Heijer T, Launer LJ, de Groot JC, de Leeuw FE, Oudkerk M, van Gijn J, et al. Serum carotenoids and cerebral white matter lesions: the Rotterdam scan study. J Am Geriatr Soc 2001;49:642-646.
16. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol 1987;149:351-356.
17. Ito Y, Ochiai J, Sasaki R, Suzuki S, Kusuhara Y, Morimitsu Y, et al. Serum concentrations of carotenoids, retinol, and alpha-tocopherol in healthy persons determined by high-performance liquid chromatography. Clin Chim Acta 1990;194:131-144.
18. de Leeuw FE, Richard F, de Groot JC, van Duijn CM, Hofman A, Van Gijn J, et al. Interaction between hypertension, apoE, and cerebral white matter lesions. Stroke 2004;35:1057-1060.
19. McCarty MF. Gamma-tocopherol may promote effective no synthase function by protecting tetrahydrobiopterin from peroxynitrite. Med Hypotheses 2007;69:1367-1370.
20. Information Sfhan. The national health and nutrition survey in Japan, 2005; 2008:72-84.
21. Vermeer SE, van Dijk EJ, Koudstaal PJ, Oudkerk M, Hofman A, Clarke R, et al. Homocysteine, silent brain infarcts, and white matter lesions: The Rotterdam Scan Study. Ann Neurol 2002;51:285-289.
22. Censori B, Partziguian T, Manara O, Poloni M. Plasma homocysteine and severe white matter disease. Neurol Sci 2007;28:259-263.
23. Wong A, Mok V, Fan YH, Lam WW, Liang KS, Wong KS. Hyperhomocysteinemia is associated with volumetric white matter change in patients with small vessel disease. J Neurol 2006;253:441-447.
24. Longstreth WT, Jr., Katz R, Olson J, Bernick C, Carr JJ, Malinow MR, et al. Plasma total homocysteine levels and cranial magnetic resonance imaging findings in elderly persons: the Cardiovascular Health Study. Arch Neurol 2004;61:67-72.
25. Khan U, Crossley C, Kalra L, Rudd A, Wolfe CD, Collinson P, et al. Homocysteine and Its Relationship to Stroke Subtypes in a UK Black Population. The South London Ethnicity and Stroke Study. Stroke 2008.